MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
Glucose tracking is moving beyond diabetes care as CGMs, AI platforms, and wearable sensors reshape personalized health data ...